Status:
RECRUITING
Evaluation of Blood Loss After Cesarean Delivery Via US Compared to Standard Care
Lead Sponsor:
Holy Family Hospital, Nazareth, Israel
Conditions:
Postpartum Period
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
Postpartum hemorrhage and anemia are considered a major health concern due to their impact on maternal morbidity and mortality, quality of life, and maternal cognitive and emotional functioning after ...
Detailed Description
According to the World Health Organization, postpartum anemia should be recognized as a major health concern, as it affects the quality of life, cognitive and emotional function of the mother, which a...
Eligibility Criteria
Inclusion
- Women who delivered by a cesarean section.
- Age over 18.
- Fluent in Hebrew or Arabic.
- Signed informed consent form.
Exclusion
- Lack of consent or inability to provide informed consent.
- Inability to perform a post-surgical ultrasound, such as post-surgery hospitalization in the intensive care unit.
- Women with preoperative coagulation disorders.
- Women whose clinical condition requires a post-cesarean ultrasound examination.
Key Trial Info
Start Date :
May 8 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
276 Patients enrolled
Trial Details
Trial ID
NCT06963047
Start Date
May 8 2025
End Date
June 1 2026
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Holy family hospital
Nazareth, North, Israel